Conferences - Results from #9600

Viewing 9601-9620 of 11721 articles

EAU 2017: Observation or active surveillance or curative treatment: What do PIVOT data tell us?

EAU 2017: Special session of the Prostate Cancer Prevention Group - Risk factors and biomarkers for screening and triage: Imaging-based biomarkers: mpMRI

EAU 2017: Special session of the Prostate Cancer Prevention Group - Risk factors and biomarkers for screening and triage: Tissue-based biomarkers: CCP

EAU 2017: Special session of the Prostate Cancer Prevention Group - Risk factors and biomarkers for screening and triage: Blood and urine-based biomarkers

EAU 2017: Special session of the Prostate Cancer Prevention Group - Risk factors and biomarkers for screening and triage: The role of miRNA in oncogenesis and progression

EAU 2017: Special session of the Prostate Cancer Prevention Group - Risk factors and biomarkers for screening and triage: Dietary and lifestyle factors

EAU 2017: Special session of the Prostate Cancer Prevention Group: PLCO

EAU 2017: Special session of the Prostate Cancer Prevention Group: ERSPC

EAU 2017: Special session of the Prostate Cancer Prevention Group: ProtecT

EAU 2017: Multimodal bladder preservation technique for muscle invasive bladder cancer: Results from a prospective trial

EAU 2017: Is neoadjuvant chemotherapy beneficial before radical cystectomy? Examining the external validity of the SWOG-8710 trial

EAU 2017: Comparative effectiveness of selective adjuvant versus systematic neoadjuvant chemotherapy-based strategy for muscle-invasive urothelial carcinoma of the bladder

EAU 2017: Pembrolizumab produces clinically meaningful responses as first-line therapy in cisplatin-ineligible advanced urothelial cancer: Results from subgroup analyses of KEYNOTE-052

EAU 2017: 4th ESO Prostate Cancer Observatory: The Urologist’s Perspective on Active Surveillance

EAU 2017: 4th ESO Prostate Cancer Observatory: The Imaging Specialist’s Perspective on MRI

EAU 2017: 4th ESO Prostate Cancer Observatory: The Pathologist’s Perspective

EAU 2017: 4th ESO Prostate Cancer Observatory: The Radiation Oncologist’s Perspective

EAU 2017: 4th ESO Prostate Cancer Observatory: The Medical Oncologist’s Perspective

EAU 2017: 4th ESO Prostate Cancer Observatory: The Imaging Specialist’s Perspective on PSMA

EAU 2017: What is the optimal post-operative management of men with lymph node recurrent prostate cancer after salvage lymph node dissection? Results from a large, multi-institutional series

476
477
478
479
480
481
482
483
484
485